(S (NP (NP (DT The) (NN exploration)) (PP (IN of) (NP (JJ novel) (NN chemical) (NNS spaces)))) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ important)) (NNS tasks)) (PP (IN of) (NP (NNS cheminformatics)))))) (SBAR (WHADVP (WRB when)) (S (VP (VBG supporting) (NP (DT the) (NN drug) (NN discovery) (NN process)))))) (. .))
(S (S (VP (ADVP (RB Properly)) (VBN designed) (CC and) (VBN trained))) (NP (JJ deep) (JJ neural) (NNS networks)) (VP (MD can) (VP (VB provide) (NP (NP (DT a) (JJ viable) (JJ alternative)) (PP (TO to) (NP (NP (NN brute-force) (FW de) (FW novo) (NNS approaches)) (CC or) (NP (JJ various) (JJ other) (NN machine-learning) (NNS techniques)))) (PP (IN for) (S (VP (VBG generating) (NP (JJ novel) (JJ drug-like) (NNS molecules)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN article))) (NP (PRP we)) (VP (VP (VBP present) (NP (NP (DT a) (NN method)) (SBAR (S (VP (TO to) (VP (VB generate) (NP (NNS molecules)) (S (VP (VBG using) (NP (DT a) (ADJP (JJ long) (JJ short-term) (NN memory) (PRN (-LRB- -LRB-) (NNP LSTM) (-RRB- -RRB-))) (JJ neural) (NN network)))))))))) (CC and) (VP (VB provide) (NP (NP (DT an) (NN analysis)) (PP (IN of) (NP (DT the) (NNS results))) (, ,) (PP (VBG including) (NP (DT a) (JJ virtual) (NN screening) (NN test)))))) (. .))
(S (S (VP (VBG Using) (NP (DT the) (NN network)))) (NP (QP (CD one) (CD million)) (JJ drug-like) (NNS molecules)) (VP (VBD were) (VP (VBN generated) (PP (IN in) (NP (CD 2) (NNS hours))))) (. .))
(S (NP (DT The) (NNS molecules)) (VP (VBP are) (ADJP (JJ novel)) (, ,) (ADJP (JJ diverse)) (PRN (-LRB- -LRB-) (S (VP (VBP contain) (NP (JJ numerous) (JJ novel) (NNS chemotypes)))) (-RRB- -RRB-)) (, ,) (VP (VBP have) (NP (JJ good) (JJ physicochemical) (NNS properties))) (CC and) (VP (VBP have) (NP (JJ good) (JJ synthetic) (NN accessibility))) (, ,) (SBAR (RB even) (IN though) (S (NP (DT these) (NNS qualities)) (VP (VBD were) (RB not) (NP (JJ specific) (NNS constraints)))))) (. .))
(S (SBAR (IN Although) (FRAG (NP (NN novel)))) (, ,) (NP (PRP$ their) (NX (NX (JJ structural) (NNS features)) (CC and) (NX (JJ functional) (NNS groups)))) (VP (VBP remain) (PP (ADVP (RB closely)) (IN within) (NP (NP (DT the) (JJ drug-like) (NN space)) (VP (VBN defined) (PP (IN by) (NP (NP (DT the) (JJ bioactive) (NNS molecules)) (PP (IN from) (NP (NNP ChEMBL))))))))) (. .))
(S (NP (NP (JJ Virtual) (NN screening)) (VP (VBG using) (NP (DT the) (NN profile) (NNP QSAR) (NN approach)))) (VP (VBZ confirms) (SBAR (IN that) (S (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (DT these) (JJ novel) (NNS molecules))) (S (VP (TO to) (VP (VB show) (NP (NN bioactivity)))))) (VP (VBZ is) (ADJP (JJ comparable) (PP (TO to) (NP (NP (DT the) (NNP ChEMBL) (NN set)) (SBAR (WHPP (IN from) (WHNP (WDT which))) (S (NP (PRP they)) (VP (VBD were) (VP (VBN derived)))))))))))) (. .))
(S (NP (NP (DT The) (NN molecule) (NN generator)) (VP (VBN written) (PP (IN in) (NP (NNP Python)))) (VP (VBD used) (PP (IN in) (NP (DT this) (NN study))))) (VP (VBZ is) (ADJP (JJ available) (PP (IN on) (NP (NN request))))) (. .))
